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Abstract
Background
Changes in physical activity (PA) are difficult to interpret because no framework of minimal
important difference (MID) exists. We aimed to determine the minimal important difference
(MID) in physical activity (PA) in patients with Chronic Obstructive Pulmonary Disease and to
clinically validate this MID by evaluating its impact on time to first COPD-related hospitalization.
Methods
PAwas objectively measured for one week in 74 patients before and after three months of
rehabilitation (rehabilitation sample). In addition the intraclass correlation coefficient wasmea-
sured in 30 patients (test-retest sample), by measuring PA for two consecutive weeks. Daily
number of steps was chosen as outcomemeasurement. Different distribution and anchor
based methods were chosen to calculate the MID. Time to first hospitalization due to an
exacerbation was compared between patients exceeding the MID and those who did not.
Results
Calculation of the MID resulted in 599 (Standard Error of Measurement), 1029 (empirical
rule effect size), 1072 (Cohen's effect size) and 1131 (0.5SD) steps.day-1. An anchor based
estimation could not be obtained because of the lack of a sufficiently related anchor. The
time to the first hospital admission was significantly different between patients exceeding
the MID and patients who did not, using the Standard Error of Measurement as cutoff.
Conclusions
The MID after pulmonary rehabilitation lies between 600 and 1100 steps.day-1. The clinical
importance of this change is supported by a reduced risk for hospital admission in those
patients with more than 600 steps improvement.
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Introduction
Physical inactivity is an important predictor of worse outcome in Chronic Obstructive Pulmo-
nary Disease (COPD), resulting in an increased risk of hospital admission and mortality [1].
Patients with COPD are less active compared to age matched controls and this inactivity wors-
ens with increasing disease severity [2]. Independent of the disease severity, physical activity
decreases over time and a sustained physical inactivity is associated with a progression of exer-
cise intolerance and muscle depletion [3]. Therefore, assessing and increasing physical activity
(PA) has gained importance in COPD management [2]. Objective measures of PA do not rely
on information provided by the patient and can give a valid presentation of the physical activity
level in this slow walking population [4,5]. This gives the ability to investigate the effect of
interventions on the PA level. Pulmonary rehabilitation, the most effective non-pharmacologi-
cal treatment, increases PA to a statistically significant extent [6], equivalent to five minutes
more activity per day [7]. The interpretation of the increase seen after pulmonary rehabilitation
remains difficult as the minimal important difference (MID) has not yet been established [8].
The Food and Drug administration (FDA) defines the MID as “a meaningful change or
effect that might be considered important, beneficial or harmful, either by patients or informed
proxies (including clinicians) and which would lead the patient/clinician to consider a change
in management”[9]. The MID has become the standard approach for the interpretation of clin-
ically relevant changes of an intervention and is well-established to guide changes in treatment
decisions (by clinicians) and to calculate sample sizes (by investigators) [10].
The MID can be derived from distribution-based methods by observing changes in a data-
base and interpreting results in terms of the relationship between the magnitude of the effect
and measures of variability. A second technique are anchor-based approaches which associate
outcomes with related concepts [9]. Because none of the approaches is perfect, the recommen-
dation is to estimate the MID based on several anchor- and distribution-based methods and
add relevant clinical or patient-based indicators and to triangulate to a single value or a small
range of values for the MID [11].
Testing whether the MID estimation based on the triangulation process is important can be
done by comparing the MID with acceptable patient-reported outcomes or clinical end-points.
In patients with COPD, acute exacerbations are independent indicators of poor prognosis [12].
Reducing the frequency and severity of exacerbations is one of the priorities in the treatment of
stable patients with COPD [13]. Patients with lower levels of PA are hospitalized more rapidly
[14] and have more exacerbations [15,16] compared to more active patients. Moreover, based
on self-report, an increase in physical activity resulted in a lower frequency of hospitalizations
for an exacerbation [17]. It could, hence, be speculated that patients with an increase exceeding
the MID should experience less severe exacerbations after pulmonary rehabilitation.
The aims of the present study were 1) to provide an estimate of the MID in physical activity
(step count) in patients with COPD and 2) to validate the clinical importance of this MID by
investigating the time to the first admission for an exacerbation in the 2 years following a reha-
bilitation program.
Methods
Study population and design
This retrospective study has been approved by UZ Leuven Medical Ethics Committee
(S58489). No informed consent from the participants was required for the present analysis. All
patient information was anonymized and de-identified prior to analysis. Eighty nine patients
formed the ‘rehabilitation sample’ and included 57 patients from an earlier study [18] as well
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as 32 newly consecutive recruited patients from this rehabilitation program between November
2011 –February 2013, in whom PAmeasurement was available as part of the clinical routine
assessment. An additional and independent ‘test-retest sample’ of 37 patients was recruited
from the multicenter PROactive trials [4,19], using patients included in our center. This cohort
was included to analyze test-retest reliability of two consecutive weeks of measurement, as this
information was not available in literature.
Inclusion criteria and content of this outpatient multidisciplinary rehabilitation are
described elsewhere [20,21].
Clinical measurements
PA was measured by the Sensewear Pro Armband (BodyMedia, Pittsburgh, PA, USA) or the
Actigraph GT3X (Actigraph LLC Pensacola, FL, USA), both accelerometers validated in
patients with COPD [4,5]. Day-by-day differences in steps were comparable between both
monitors (S1 File). In the rehabilitation sample PA was measured for one week before and one
week immediately after three months of rehabilitation. Patients in the test-retest sample were
measured for two consecutive weeks. Weekends and weekdays with less than eight hours of
wearing time were excluded from the analysis in both cohorts [18]. Patients (in both cohorts)
were excluded if they did not have at least four valid weekdays of measurement, in both weeks.
The mean number of steps per week was chosen as PA outcome.
In both samples lung function (Jaeger Master Screen Body; CareFusion; Germany) was mea-
sured according to ERS/ATS standards [22]. The results were expressed as predicted normal
values [23]. In the rehabilitation cohort two six-minute walking tests (functional exercise
capacity) and the Chronic Respiratory Disease Questionnaire (CRDQ) (health-related quality
of life) [24] were performed at baseline and after finishing the program. The dyspnea subscale
(CRDQdyspnea) and total score (CRDQtotal) were retrieved for the present investigation.
Statistical analysis
All statistical analyses were performed using the SAS statistical package (v9.3,SAS, institute,
Cary,NC,USA). P<0.05 was considered as statistically significant.
Calculation of the MID
The distribution-based techniques used are 1) standard error of measurement (SEM), 2)
empirical rule effect size, 3) cohen’s effect size and 4) 0.5 times the standard deviation (SD) of
the baseline measurement (Table 1). In the calculation of cohen’s effect size and the empirical
rule effect size, the SD of the change score was used [25]. PA changes in the rehabilitation
Table 1. Distribution-based estimates of the minimal important difference (MID).
Method MID calculation
SEM SDbaseline *sqrt (1-ICC)
Empirical rule effect size 0.08 * 6 * SDΔ
Cohen’s effect size 0.5*SDΔ
0.5 times SD 0.5*SDbaseline
SEM = standard error of measurement, SD = standard deviation (based on rehabilitation sample),
sqrt = square root, ICC = intraclass correlation coefficient (based on test-retest sample), Δ = difference in
steps (based on rehabilitation sample), baseline = number of steps at baseline (based on rehabilitation
sample)
doi:10.1371/journal.pone.0154587.t001
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sample were adjusted for daylight time between the measurement before and after rehabilita-
tion (PROCMIXED analysis including daylight as covariate) [18]. The intraclass correlation
coefficient (ICC) was calculated based on the test-retest cohort (PROCMIXED).
Anchor-based methods have two requirements, 1) the anchor must be interpretable and 2)
there must be an appreciable association between the measurement of interest and the anchor
[10] (correlation of0.5 [25]). The six-minutes walking distance (6MWD) and CRDQ are
associated with the level of PA in cross sectional analyses [1] and changes in CRDQdyspnea and
6MWD have been (although not strongly) related to changes in walking time after rehabilita-
tion [21]. Since the MID for the 6MWD, CRDQtotal score and the CRDQdyspnea domain are
well established [8], these were chosen as possible anchors. In the presence of a sufficient (pear-
son) correlation, a linear regression analysis provides the estimation, using a change of 30
meters in the 6MWD, 2.5 points in the CRDQdyspnea and 10 points for CRDQtotal score [8].
Including a relevant clinical indicator
Time to first hospital admission for an exacerbation in the two years following the three
months of rehabilitation was collected (data collection until 1st of April 2014).
A priori reasons for censoring were a restart in a rehabilitation program, transplantation,
cancer, a cerebrovascular accident, severe cardiovascular events (need for ICU stay) and loss of
contact with the patient. No censoring was done for mild (without stay in the ICU) cardiovas-
cular events.
Kaplan-Meier curves of time to first admission during follow up were built representing PA
of patients exceeding the MID and those who didn’t, using each of the calculated MIDs. Differ-
ences were analyzed using a Cox proportional hazard regression analysis (proc phreg) with
each calculated MID as class variable. Statistical differences and the hazard ratios (+95% confi-
dence intervals) between patients exceeding the MID and patients who don’t were retrieved. In
an additional analysis, the baseline PA (Stepsbaseline) and disease severity (FEV1%predbaseline)
were included in the regression analysis to verify whether the difference was not solely
explained by these important predictors of hospitalization risk.
Results
Patient characteristics
Fifteen patients in the rehabilitation sample were excluded because of an insufficient number
of valid days. In the test-retest sample seven patients were excluded based on the PA criteria.
There was no baseline difference between included and excluded patients, in both cohorts (S1
File). The rehabilitation (n = 74) and test-retest (n = 30) samples were comparable at baseline
(Table 2).
Calculation of the MID
Patients, respectively in the test-retest and rehabilitation sample, wore the monitor for a mean
±SD of 4.9±0.4 weekdays with a wearing time of 962±233 minutes and 4.8±0.4 weekdays with
a wearing time of 873±210 minutes.
The ICC between test and retest was 0.93 (daily steps week1 4230±2093, week2 4060±2148,
p = 0.76). Patients in the rehabilitation cohort significantly increased their PA level with 805
±2144 steps (p = 0.002), adjusted for a difference in daylight time (mean 0.7±274 minutes).
Table 3 summarizes the different MID estimations using distribution-based techniques. The
MID ranges between 599 and 1131 steps. Unadjusted estimates only differed minimally from
those including daylight time as covariate.
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Patients significantly improved their functional exercise capacity and CRDQ score
(Table 4). Neither the change in 6MWD (r = 0.20, p = 0.09), nor the change in CRDQdyspnea
score (r = 0.29, p = 0.02) or CRDQtotal score (r = 0.16, p = 0.27) were moderately correlated
with the change in PA and could therefore not be used as reliable anchors (Fig 1). Excluding
the outliers did not improve the presented correlations.
Validation of the MID estimation
Three patients restarted a rehabilitation program, one patient was censored based on a cerebro-
vascular accident, two based on diagnosis of cancer (one sigmoid carcinoma, one pancreatic
cancer), three patients were transplanted (two lung, one liver transplantation) and in two
patients no reliable date of first hospitalization could be retrieved because of loss of contact
after respectively four and six months.
During the mean (min-max) follow up period of 632 (341–720) days, 35% of participants
had at least one hospital admission due to acute exacerbation. Time to first COPD admission
in two years following the rehabilitation was shorter for patients not exceeding the MID
according to the SEM (p = 0.01). Similar, though not statistically significant, trends were
observed when using other cutoffs (Fig 2 and Table 5). Adjusting the analysis for lung function
severity and baseline physical activity did not change the estimates (Table 5). Including all
patients with at least two valid days of PA measurement (n = 86) did not change the results (S1
File).
Discussion
The present study provides an estimation (between 599 and 1131 steps.day-1) and clinical vali-
dation of the MID in PA for patients with COPD. Patients who exceeded the MID show a
Table 2. Baseline characteristics.
Parameter Rehabilitation sample (n = 74) Test-retest sample (n = 30) p-value$
Age (years) 66 ± 7 67 ± 7 0.36
BMI (kg.m-2) 26 ± 6 27 ± 6 0.49
Gender (Male)* 56 (76) 23 (77) 0.91
6MWD (m) 409 ± 120 457 ± 113 0.06
FEV1 (%pred) 48 ± 22 48 ± 12 0.93
Steps (n.day-1) 3839 ± 2262 4230 ± 2093 0.42
Data expressed as mean ± SD
* = data expressed as n (%)
$ = between group differences analysed using an unpaired ttest or chi-square test(*)
doi:10.1371/journal.pone.0154587.t002
Table 3. Distribution-based methods to estimate the minimal important difference (MID) in physical
activity.
Method MID (steps.day-1)
SEM 599
Empirical rule effect size 1029
Cohen’s effect size 1072
0.5 times SD 1131
SEM = standard error of measurement, SD = standard deviation
doi:10.1371/journal.pone.0154587.t003
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decreased risk for a hospital admission in the first two years after rehabilitation, providing
validity to the proposed MID.
The present study included different distribution-based estimations, resulting in a range
mainly varying based on the chosen SD in the calculation [25]. Because intervention studies
focus on changes over time, calculations based on SD of the change seem more appropriate.
The most established and used method is the SEM, which is expressed in the original metric of
the instrument (steps) and is by definition sample independent [26]. Our results confirm the
clinically meaningfulness of the 1-SEM criterion [26]. Other possible methods of MID estima-
tion are including a global rating of change questionnaire (within patient) or interpatient com-
parison [27]. These techniques could not be included because of the retrospective design of this
study. Pedometer-based interventions in COPD elicit a weighted increase of 562 steps per day
[28]. More recently published coaching trials showed larger increases up to 3000 steps [29,30],
showing the feasibility of the MID as described in the present study. Nevertheless, in e.g. phar-
macological studies, aiming for an increase of 600 steps will still be challenging and require a
decent sample size as PA measurements demonstrate large variability, even after proper stan-
dardization [18]. The availability of a Minimal Important Difference can assist the design and
interpretation of future studies aiming to enhance PA. On one hand the MID can form the
basis of the sample size calculation and on the other hand the MID will help the interpretation
Table 4. Benefits after rehabilitation (rehabilitation sample, n = 74).
Parameter Pre rehabilitation Post rehabilitation Δ p-value$
Steps (n.day-1) 3839 ± 2262 4644 ± 3003 805 ± 2193 0.002
6MWD (m) 409 ± 120 459 ± 114 48 ± 76 <0.001
CRDQdyspnea 15 ± 5 22 ± 6 7 ± 5 <0.001
CRDQtotal 77 ± 14 97 ± 15 19 ± 13 <0.001
Data expressed as mean ± SD; CRDQdyspnea baseline was missing in 5 patients, 6MWD at 3 months was missing in 3 patients, CRDQdyspnea at 3 months
was missing in 10 patients; CRDQtotal score reported based on 50 patients; Δsteps data present unadjusted data (adjusted Δ805±2144 steps.day
-1).
$ = within group differences analysed using a paired ttest
doi:10.1371/journal.pone.0154587.t004
Fig 1. Correlation between change in daily step count and possible anchors. a) 6MWD and b) CRDQdyspnea in the rehabilitation sample (n = 74); 6MWD
after 3 months was missing in 3 patients, CRDQdyspnea scores were missing in 10 patients.
doi:10.1371/journal.pone.0154587.g001
MID in Physical Activity in Patients with COPD
PLOSONE | DOI:10.1371/journal.pone.0154587 April 28, 2016 6 / 11
of findings. Ideally, new interventions should aim to increases exceeding the present MID esti-
mate, which can then consequently, at the group level, be interpreted as clinically relevant.
Alternatively, ‘number needed to treat’ can be calculated based on the available MID.
We selected time to first hospital admission as an important clinical indicator. The aim of
this validation is only to evaluate whether a threshold, known to be statistically relevant, can be
translated to clinical relevance and did not intend to identify independent predictors of admis-
sions nor aimed to identify the best discriminant steps value for better clinical outcomes in gen-
eral. Similarly, whether smaller increases would already have a positive effect on hospital
admission or would lead to other clinical benefits (e.g. cardiovascular prevention) is not known
but goes beyond the scope of this study. Nevertheless our data are in line with previous
research concluding higher physical activity [31,32] and an increase of steps [33] being protec-
tive of severe acute exacerbations.
To the best of our knowledge the present study is the first identifying the MID in objectively
measured PA in patients with COPD [8]. The MID in the London Chest Activity of Daily Liv-
ing Scale has already been reported [34]. Multiple sclerosis is the only disease in which the
MID has been calculated for steps. This MID lays in the same order of magnitude compared to
the present study: 779 steps per day [35]. Although most recommendations of PA include
other variables, we chose only daily step count as outcome measurement. Beside the fact that
this variable is easy to understand and highly used in clinical practice, this choice was based on
our previous data showing step counts to be a more sensitive outcome to detect changes [18].
In addition we used two activity monitors and step counts between both are sufficiently similar.
This may not be the same for other outcomes that are relying on proprietary algorithms.
Whether other outcomes of activity would correlate sufficiently with the proposed anchors and
allow an estimation based on triangulation is not known and ground for further investigation.
Fig 2. Time to first hospitalization. difference between patients exceeding the MID (dotted line) and patients not exceeding the MID (solid line), based on a)
SEM cutoff, b) empirical rule effect size and c) cohen effect size and 0.5 SD.
doi:10.1371/journal.pone.0154587.g002
Table 5. Time to first hospitalization between patients who exceed the MID and patients who don’t.
MID Exceeding MID n (%) HR (95%CI) p-value HR (95%CI)a p-value a
SEM 31 (42) 3.08 (1.28–7.43) 0.01 3.07 (1.27–7.41) 0.01
Empirical rule effect size 25 (34) 2.24 (0.89–5.64) 0.09 2.24 (0.89–5.66) 0.09
Cohen’s effect size 24 (32) 2.03 (0.81–5.08) 0.13 1.99 (0.79–5.04) 0.15
0.5 times SD 24 (32) 2.03 (0.81–5.08) 0.13 1.99 (0.79–5.04) 0.15
HR = hazard ratio, 95%CI = 95% confidence interval, SD = standard deviation
a adjusted for baseline PA (STEPSbaseline) and baseline disease severity (FEV1%predbaseline)
doi:10.1371/journal.pone.0154587.t005
MID in Physical Activity in Patients with COPD
PLOSONE | DOI:10.1371/journal.pone.0154587 April 28, 2016 7 / 11
Despite aiming to include multiple methods in the MID estimation and add a clinical vali-
dation, some limitations exist. This retrospective study included PA data measured with 2
(valid) activity monitors. Although previous research suggest the Sensewear Armband to be
less accurate in measuring step counts [36], the correlation between day-by-day differences in
step count obtained by both devices was high and both devices resulted in the same trends of
differences in the validation of the MID (both in S1 File). A second limitation is the inclusion
of two cohorts. Because these cohorts show comparable disease severity and PA levels, this
would unlikely have changed the MID estimates. A third limitation is that we were not able to
relate a minimal change to patient-important aspects due to the lack of anchor-based method-
ology. The present study provides further evidence to the concept that PA is a particular feature
of patients’ health and is poorly captured by exercise tests and health status patient reported
outcome tools. Because distribution-based approaches only provide an indication of the MID
based on statistical criteria it has been highly recommended to add multiple anchor based-
approaches in the estimation. Previous research concluded slightly better correlations between
PA and our proposed anchors [21], however, also not reaching the requirements for anchor-
based estimations. In addition, we validated the MID using a clinical important indicator, sup-
porting the present results. Although the use of higher cutoffs did not reach statistically signifi-
cant differences between patients exceeding the MID and patients who did not, we are
confident that this analysis provides a decent validation because similar trends are observed at
these cut-points. Research using larger samples would probably be able to confirm this. A pos-
sible bias of the presented study is the inclusion of patients referred for a multidisciplinary
rehabilitation program, representing the rather inactive patients, as well as only including
patients who successfully finished rehabilitation, which was crucial to obtain a valid estimate of
changes in PA. Further research is needed in a cohort representing a broader spectrum of PA
levels to confirm the present results.
Estimation of a MID is important in the interpretation of interventions as it goes beyond
the interpretation of the concept of statistical differences. Besides giving an estimation of this
meaningful increase, our data show the clinical importance of this change. As with all MIDs,
individual patients may perceive a worthwhile benefit below or above this estimation, since
these estimates are based on groups of patients. It should be noted that the MID possibly varies
across patient groups [9] and that the obtained MID might be intervention-specific (if the vari-
ance of the effect would be different between interventions [37]). Our data would support that
interventions yielding an increase of 600–1100 steps yield clinically important benefits to
patients with COPD. Further research is needed to confirm the estimation in the PA in COPD,
including other interventions, avoiding the bias of a single study estimation. As part of the
IMI-JU PROactive project (www.proactivecopd.com) large intervention studies were con-
ducted, investigating the effect of drugs (EudraCT 2013-002671-18), pulmonary rehabilitation
(NCT02437994) and telecoaching interventions (NCT02158065) on physical activity. These
studies, besides others, could help confirming the present results in different interventional
paradigms.
Conclusions
The Minimal Important Difference in daily step count after pulmonary rehabilitation, based
on distribution-based calculations, lies between 600 and 1100 steps per day. An anchor-based
approach could not be used because of the lack of well-related anchors. The clinical importance
of this change is supported by a reduced risk for hospital admission in those patients with
more than 600 steps improvement after pulmonary rehabilitation. Future research is needed to
confirm this estimation based on data from one single center.
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S1 File. Online Supplement. Online data supplement including patient characteristics and
additional data analyses including the relation between the 2 activity monitors and sensitivity
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(TIF)
S2 Fig. Time to first hospitalization including all patients with at least 2 days of measure-
ment.
(TIF)
S3 Fig. Time to first hospitalization according to the activity monitor used.
(TIF)
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